There is also evidence of miR-9-5p having an oncogenic activity; EGFR activation has been suggested to upregulate miR-9-5p in HPV-negative HNSCC and high miR-9-5p expression is associated with poor patient prognosis [31]. This evidence concerns the gene EGFR and head and neck squamous cell carcinoma.